Median cTnT was 8.9 (interquartile range [IQR]: 6.4–13.3) ng/L in participants with insomnia symptoms as compared to 8.0 (IQR: 5.8–11.5) ng/L in those without insomnia symptoms (Table 2). The gene discussed is TNNT2; the disease is insomnia measurement.